[Federal Register Volume 78, Number 18 (Monday, January 28, 2013)]
[Notices]
[Page 5812]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-01649]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting of the aforementioned
committee:
Times and Dates
8:00 a.m.-5:00 p.m., February 20, 2013, 8:00 a.m.-3:00 p.m.,
February 21, 2013.
Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton
Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia
30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director, CDC,
on the appropriate uses of immunizing agents. In addition, under 42
U.S.C. 1396s, the committee is mandated to establish and periodically
review and, as appropriate, revise the list of vaccines for
administration to vaccine-eligible children through the Vaccines for
Children (VFC) program, along with schedules regarding the appropriate
periodicity, dosage, and contraindications applicable to the vaccines.
Further, under provisions of the Affordable Care Act, at section 2713
of the Public Health Service Act, immunization recommendations of the
ACIP that have been adopted by the Director of the Centers for Disease
Control and Prevention must be covered by applicable health plans.
Matters To Be Discussed: The agenda will include discussions on:
adult immunization, general recommendations, 13-valent pneumococcal
conjugate vaccine, influenza, Japanese encephalitis vaccine, pertussis,
Haemophilus influenzae b (Hib) vaccine, smallpox and vaccine supply.
Recommendation votes are scheduled for Hib vaccine, influenza and 13-
valent pneumococcal conjugate vaccine. VFC votes are scheduled for
Haemophilus influenzae b (Hib) vaccine and 13-valent pneumococcal
conjugate vaccine. Time will be available for public comment. Agenda
items are subject to change as priorities dictate.
Contact Person for More Information: Stephanie B. Thomas, National
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton
Road, NE., MS-A27, Atlanta, Georgia 30333, Telephone: (404) 639-8836;
Email [email protected].
Meeting is Web cast live via the World Wide Web; for instructions
and more information on ACIP please visit the ACIP Web site: http://www.cdc.gov/vaccines/acip/index.html.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Dated: January 22, 2013.
Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2013-01649 Filed 1-25-13; 8:45 am]
BILLING CODE 4160-18-P